As of 2025-12-20, the EV/EBITDA ratio of Precigen Inc (PGEN) is -6.81. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. PGEN's latest enterprise value is 1,607.07 mil USD. PGEN's TTM EBITDA according to its financial statements is -235.99 mil USD. Dividing these 2 quantities gives us the above PGEN EV/EBITDA ratio.
Note: valuation result may not be accurate due to the company's negative EBITDA.
| Range | Selected | |
| Trailing P/E multiples | 13.7x - 15.2x | 14.6x |
| Forward P/E multiples | 15.1x - 22.2x | 18.8x |
| Fair Price | (10.29) - (10.33) | (11.36) |
| Upside | -338.3% - -339.2% | -363.0% |
| Date | EV/EBITDA |
| 2025-12-15 | -6.05 |
| 2025-12-12 | -5.87 |
| 2025-12-11 | -5.76 |
| 2025-12-10 | -5.60 |
| 2025-12-09 | -5.60 |
| 2025-12-08 | -5.87 |
| 2025-12-05 | -5.73 |
| 2025-12-04 | -5.96 |
| 2025-12-03 | -5.69 |
| 2025-12-02 | -5.55 |
| 2025-12-01 | -5.75 |
| 2025-11-28 | -6.08 |
| 2025-11-26 | -5.94 |
| 2025-11-25 | -5.84 |
| 2025-11-24 | -6.06 |
| 2025-11-21 | -6.15 |
| 2025-11-20 | -6.18 |
| 2025-11-19 | -6.66 |
| 2025-11-18 | -7.60 |
| 2025-11-17 | -7.68 |
| 2025-11-14 | -7.60 |
| 2025-11-13 | -6.12 |
| 2025-11-12 | -6.36 |
| 2025-11-11 | -6.27 |
| 2025-11-10 | -6.33 |
| 2025-11-07 | -6.18 |
| 2025-11-06 | -6.21 |
| 2025-11-05 | -6.32 |
| 2025-11-04 | -6.15 |
| 2025-11-03 | -6.57 |
| 2025-10-31 | -6.54 |
| 2025-10-30 | -6.40 |
| 2025-10-29 | -6.35 |
| 2025-10-28 | -6.42 |
| 2025-10-27 | -6.78 |
| 2025-10-24 | -6.82 |
| 2025-10-23 | -6.70 |
| 2025-10-22 | -6.20 |
| 2025-10-21 | -6.45 |
| 2025-10-20 | -6.24 |
| 2025-10-17 | -6.33 |
| 2025-10-16 | -5.57 |
| 2025-10-15 | -5.63 |
| 2025-10-14 | -5.13 |
| 2025-10-13 | -5.15 |
| 2025-10-10 | -5.01 |
| 2025-10-09 | -5.12 |
| 2025-10-08 | -5.16 |
| 2025-10-07 | -5.30 |
| 2025-10-06 | -5.04 |